Title |
Endothelial perturbations and therapeutic strategies in normal tissue radiation damage
|
---|---|
Published in |
Radiation Oncology, December 2014
|
DOI | 10.1186/s13014-014-0266-7 |
Pubmed ID | |
Authors |
Elina Korpela, Stanley K Liu |
Abstract |
Most cancer patients are treated with radiotherapy, but the treatment can also damage the surrounding normal tissue. Radiotherapy side-effects diminish patients¿ quality of life, yet effective biological interventions for normal tissue damage are lacking. Protecting microvascular endothelial cells from the effects of irradiation is emerging as a targeted damage-reduction strategy. We illustrate the concept of the microvasculature as a mediator of overall normal tissue radiation toxicity through cell death, vascular inflammation (hemodynamic and molecular changes) and functional capacity. Endothelial cell targeted therapies that protect against such endothelial cell perturbations and the development of acute normal tissue damage are mostly under preclinical development. Since acute radiation toxicity is a common clinical problem in cutaneous, gastrointestinal and mucosal tissues, we also focus on damage in these tissues. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 2% |
Canada | 1 | 2% |
Unknown | 49 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 25% |
Student > Bachelor | 7 | 14% |
Student > Master | 7 | 14% |
Researcher | 5 | 10% |
Student > Doctoral Student | 3 | 6% |
Other | 4 | 8% |
Unknown | 12 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 25% |
Agricultural and Biological Sciences | 11 | 22% |
Biochemistry, Genetics and Molecular Biology | 10 | 20% |
Physics and Astronomy | 3 | 6% |
Chemical Engineering | 1 | 2% |
Other | 1 | 2% |
Unknown | 12 | 24% |